Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 26, 1994 - Issue 1
Submit an article Journal homepage
477
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Psychedelic and Entactogenic Drugs in the Treatment of Depression

Thomas J. Riedlinger Botanical Museum of Harvard University and Harvard Divinity School, Cambridge, Massachusetts
&
June E. Riedlinger Massachusetts College of Pharmacy and Allied Health Sciences, Boston, Massachusetts
Pages 41-55 | Published online: 23 Jan 2012

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Anne C. Wagner, Michael C. Mithoefer, Ann T. Mithoefer & Candice M. Monson. (2019) Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example. Journal of Psychoactive Drugs 51:2, pages 166-173.
Read now
Jerrold S Meyer. (2013) 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Substance Abuse and Rehabilitation 4, pages 83-99.
Read now
José Carlos Bouso, Rick Doblin, Magí Farré, Miguel Ángel Alcázar & Gregorio Gómez-Jarabo. (2008) MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder. Journal of Psychoactive Drugs 40:3, pages 225-236.
Read now
Arthur Hastings. (2006) An Extended Nondrug MDMA-Like Experience Evoked Through Posthypnotic Suggestion. Journal of Psychoactive Drugs 38:3, pages 273-283.
Read now
AlanaR. Pentney. (2001) An Exploration of the History and Controversies Surrounding MDMA and MDA. Journal of Psychoactive Drugs 33:3, pages 213-221.
Read now
Charles S. Grob. (2000) Deconstructing Ecstasy: The Politics Of Mdma Research. Addiction Research 8:6, pages 549-588.
Read now
PedroL. Delgado & FranciscoA. Moreno. (1998) Hallucinogens, Serotonin and Obsessive-Compulsive Disorder. Journal of Psychoactive Drugs 30:4, pages 359-366.
Read now

Articles from other publishers (22)

Cody Sykes Gilbert, Mitch Earleywine, Maha N. Mian & Brianna R. Altman. (2021) Symptom specificity of ayahuasca's effect on depressive symptoms. Journal of Psychedelic Studies 5:1, pages 37-43.
Crossref
Rafael Guimarães dos Santos, Jaime EC Hallak, Glen Baker & Serdar Dursun. (2021) Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action. Journal of Psychopharmacology 35:4, pages 453-458.
Crossref
Antonio Inserra, Danilo De Gregorio & Gabriella Gobbi. (2020) Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews 73:1, pages 202-277.
Crossref
Funda InanTibor M. Brunt, Ramon R. ContrucciLaura HondebrinkEric J. F. Franssen. (2020) Novel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review. Therapeutic Drug Monitoring 42:2, pages 271-281.
Crossref
Patricio Sáez-Briones, Vicente Castro-Castillo, Gabriela Díaz-Véliz, Luis Valladares, Rafael Barra, Alejandro Hernández & Bruce K. Cassels. (2019) Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT). Frontiers in Pharmacology 10.
Crossref
Lee E. Dunlap, Anne M. Andrews & David E. Olson. (2018) Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine. ACS Chemical Neuroscience 9:10, pages 2408-2427.
Crossref
Christian Sueur. (2018) État des lieux de la recherche sur les capacités thérapeutiques des « substances hallucinogènes » au 21 e  siècle. Psychotropes Vol. 23:3, pages 125-163.
Crossref
Elizabeth G. Pitts, Daniel W. Curry, Karly N. Hampshire, Matthew B. Young & Leonard L. Howell. (2017) (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA. Psychopharmacology 235:2, pages 377-392.
Crossref
Kevin S. Murnane. 2018. Psychedelic Neuroscience. Psychedelic Neuroscience 25 67 .
Janis Phelps. (2017) Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology 57:5, pages 450-487.
Crossref
Enrico Facco, Daniela Lucangeli & Patrizio Tressoldi. (2017) On the Science of Consciousness: Epistemological Reflections and Clinical Implications. EXPLORE 13:3, pages 163-180.
Crossref
Clinton E Canal & Kevin S Murnane. (2016) The serotonin 5-HT 2C receptor and the non-addictive nature of classic hallucinogens . Journal of Psychopharmacology 31:1, pages 127-143.
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi & Jaime E. C. Hallak. (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 6:3, pages 193-213.
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa & Jaime E. C. Hallak. (2016) Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies. Revista Brasileira de Psiquiatria 38:1, pages 65-72.
Crossref
Alicia L. Danforth, Christopher M. Struble, Berra Yazar-Klosinski & Charles S. Grob. (2016) MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 237-249.
Crossref
Rainer Kraehenmann, Katrin H. Preller, Milan Scheidegger, Thomas Pokorny, Oliver G. Bosch, Erich Seifritz & Franz X. Vollenweider. (2015) Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Biological Psychiatry 78:8, pages 572-581.
Crossref
Ly Binh T.Richard F. Clark & Saralyn R. Williams. 2010. Rosen's Emergency Medicine – Concepts and Clinical Practice. Rosen's Emergency Medicine – Concepts and Clinical Practice 2010 2018 .
Piotr Popik, Tomasz Kos, Magdalena Sowa-Kućma & Gabriel Nowak. (2008) Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology 198:3, pages 421-430.
Crossref
A. C. Parrott. (2007) The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review. Psychopharmacology 191:2, pages 181-193.
Crossref
Karl R. Hanes. (2001) Antidepressant Effects of the Herb Salvia Divinorum: A Case Report. Journal of Clinical Psychopharmacology 21:6, pages 634-635.
Crossref
Michael Winkelman. (2016) Psychointegrators: Multidisciplinary Perspectives on the Therapeutic Effects of Hallucinogens. Complementary health practice review 6:3, pages 219-237.
Crossref
Karl R. Hanes. (1996) Serotonin, Psilocybin, and Body Dysmorphic Disorder. Journal of Clinical Psychopharmacology 16:2, pages 188-189.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.